{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:20:10Z","timestamp":1792750810989,"version":"4.5.0"},"reference-count":179,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.arr.2021.101492","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T02:57:03Z","timestamp":1634698623000},"page":"101492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Current research status of blood biomarkers in Alzheimer\u2019s disease: Diagnosis and prognosis"],"prefix":"10.1016","volume":"72","author":[{"given":"Lei","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2021.101492_bib1","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00775-019-01731-9","article-title":"Redox active metals in neurodegenerative diseases","volume":"24","author":"Acevedo","year":"2019","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.arr.2021.101492_bib2","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3233\/JAD-170662","article-title":"Metals and Alzheimer\u2019s disease: how far have we come in the clinic?","volume":"62","author":"Adlard","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib3","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1007\/s12035-019-1501-x","article-title":"SNAP-25 in serum is carried by exosomes of neuronal origin and is a potential biomarker of Alzheimer\u2019s disease","volume":"56","author":"Agliardi","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2021.101492_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40478-018-0649-3","article-title":"Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration","volume":"7","author":"Ashton","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.arr.2021.101492_bib5","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/alz.12282","article-title":"Regional brain iron associated with deterioration in Alzheimer\u2019s disease: a large cohort study and theoretical significance","volume":"17","author":"Ayton","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib6","article-title":"Biomarker potential of brain-secreted extracellular vesicles in blood in Alzheimer\u2019s disease","volume":"12","author":"Badhwar","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib7","first-page":"57","article-title":"Elevated plasma levels of soluble TNFRs and TACE activity in Alzheimer\u2019s disease patients of Northern Han Chinese descent","volume":"10","author":"Bai","year":"2013","journal-title":"Curr. Alzheimer Res."},{"issue":"2","key":"10.1016\/j.arr.2021.101492_bib8","article-title":"Dietary and lifestyle guidelines for the prevention of Alzheimer\u2019s disease","volume":"35","author":"Barnard","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2021.101492_bib9","first-page":"217","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease","author":"Barthelemy","year":"2020","journal-title":"J. Exp. Med."},{"issue":"180","key":"10.1016\/j.arr.2021.101492_bib10","article-title":"Identification of rare genetic variants in Italian patients with dementia by targeted gene sequencing","volume":"66","author":"Bartoletti-Stella","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2021.101492_bib11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.joca.2006.04.001","article-title":"Classification of osteoarthritis biomarkers: a proposed approach","volume":"14","author":"Bauer","year":"2006","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.arr.2021.101492_bib12","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s00415-019-09418-6","article-title":"Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Abeta42 and T-Tau assays for Alzheimer\u2019s disease diagnosis","volume":"266","author":"Bayart","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.neurobiolaging.2013.07.017","article-title":"Validation of next-generation sequencing technologies in genetic diagnosis of dementia","volume":"35","author":"Beck","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2021.101492_bib14","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1089\/neu.2017.5553","article-title":"Longitudinal performance of plasma neurofilament light and tau in professional fighters: the professional fighters brain health study","volume":"35","author":"Bernick","year":"2018","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.arr.2021.101492_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/GIM.0b013e31816b64dc","article-title":"Genetic aspects of Alzheimer disease","volume":"10","author":"Bird","year":"2008","journal-title":"Genet. Med."},{"key":"10.1016\/j.arr.2021.101492_bib16","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3233\/JAD-170680","article-title":"Cerebrospinal fluid biomarkers for early and differential Alzheimer\u2019s disease diagnosis","volume":"62","author":"Bjerke","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1586\/14737159.5.5.661","article-title":"CSF biomarkers for Alzheimer\u2019s disease: use in early diagnosis and evaluation of drug treatment","volume":"5","author":"Blennow","year":"2005","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.arr.2021.101492_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer\u2019s disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib19","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JAD-180482","article-title":"Next generation sequencing analysis in early onset dementia patients","volume":"67","author":"Bonvicini","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib21","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/1533317510375083","article-title":"Copper and ceruloplasmin abnormalities in Alzheimer\u2019s disease","volume":"25","author":"Brewer","year":"2010","journal-title":"Am. J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/ene.13583","article-title":"Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer\u2019s disease","volume":"25","author":"Casati","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2018.08.015","article-title":"Circulating APP, NCAM and Abeta serve as biomarkers for Alzheimer\u2019s disease","volume":"1699","author":"Chen","year":"2018","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2021.101492_bib24","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1038\/s41467-020-19543-w","article-title":"Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals","volume":"11","author":"Chhatwal","year":"2020","journal-title":"Nat. Commun."},{"issue":"249\u2013257","key":"10.1016\/j.arr.2021.101492_bib25","article-title":"Plasma amyloid-beta and risk of Alzheimer\u2019s disease in the Framingham Heart Study","volume":"11","author":"Chouraki","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib26","first-page":"228","article-title":"Alzheimer\u2019s disease: early diagnosis and treatment","volume":"18","author":"Chu","year":"2012","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.arr.2021.101492_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13195-019-0564-2","article-title":"CSF synaptic protein concentrations are raised in those with atypical Alzheimer\u2019s disease but not frontotemporal dementia","volume":"11","author":"Clarke","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2021.101492_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Collaborators","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib29","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.arr.2021.101492_bib30","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jalz.2016.06.001","article-title":"Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort","volume":"12","author":"Dage","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib31","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/gepi.22211","article-title":"Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer\u2019s risk factors among 1,111 cohort participants","volume":"43","author":"Darst","year":"2018","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.arr.2021.101492_bib32","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-200176","article-title":"Metabolites associated with early cognitive changes implicated in Alzheimer\u2019s disease","volume":"79","author":"Darst","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104810","article-title":"Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying beta-amyloid pathology","volume":"139","author":"Diouf","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.arr.2021.101492_bib34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/nu9030231","article-title":"Association of serum manganese levels with Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and meta-analysis","volume":"9","author":"Du","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.arr.2021.101492_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1043-4666(03)00117-0","article-title":"In situ localization of TNFalpha\/beta, TACE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue","volume":"22","author":"Ermert","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.arr.2021.101492_bib36","first-page":"179","article-title":"Plasma amyloid beta 42\/40 ratios as biomarkers for amyloid beta cerebral deposition in cognitively normal individuals","volume":"8","author":"Fandos","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib37","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3233\/JAD-190753","article-title":"CCL23: a chemokine associated with progression from mild cognitive impairment to Alzheimer\u2019s disease","volume":"73","author":"Faura","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12883-017-1008-x","article-title":"Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease","volume":"18","author":"Feng","year":"2018","journal-title":"BMC Neurol."},{"issue":"9","key":"10.1016\/j.arr.2021.101492_bib39","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.3390\/ijms22094479","article-title":"Alteration of iron concentration in Alzheimer\u2019s disease as a possible diagnostic biomarker unveiling ferroptosis","volume":"22","author":"Ficiara","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2021.101492_bib40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s12031-019-01364-2","article-title":"Long non-coding RNA BACE1-AS may serve as an Alzheimer\u2019s disease blood-based biomarker","volume":"69","author":"Fotuhi","year":"2019","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.arr.2021.101492_bib41","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1021\/acs.jpcb.5b00175","article-title":"Tau assembly: the dominant role of PHF6 (VQIVYK) in microtubule binding region repeat R3","volume":"119","author":"Ganguly","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.arr.2021.101492_bib42","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1212\/WNL.0000000000001702","article-title":"Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease","volume":"85","author":"Goetzl","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2021.101492_bib43","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1096\/fj.201600816R","article-title":"Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer\u2019s disease","volume":"30","author":"Goetzl","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2021.101492_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.psc.2015.01.008","article-title":"Genetic testing and counseling in the diagnosis and management of young-onset dementias","volume":"38","author":"Goldman","year":"2015","journal-title":"Psychiatr. Clin. North Am."},{"key":"10.1016\/j.arr.2021.101492_bib45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40291-018-0347-7","article-title":"Alzheimer\u2019s disease and frontotemporal dementia: the current state of genetics and genetic testing since the advent of next-generation sequencing","volume":"22","author":"Goldman","year":"2018","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.arr.2021.101492_bib46","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/mp.2017.146","article-title":"Elevated plasma ferritin in elderly individuals with high neocortical amyloid-beta load","volume":"23","author":"Goozee","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2021.101492_bib47","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1007\/s12035-015-9218-y","article-title":"Factors responsible for plasma beta-amyloid accumulation in chronic kidney disease","volume":"53","author":"Gronewold","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2021.101492_bib48","first-page":"19","article-title":"Detection of aggregation-competent tau in neuron-derived extracellular vesicles","author":"Guix","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2021.101492_bib49","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2147\/CIA.S271222","article-title":"Genetic analysis of chinese patients with early-onset dementia using next-generation sequencing","volume":"15","author":"Han","year":"2020","journal-title":"Clin. Inter. Aging"},{"key":"10.1016\/j.arr.2021.101492_bib50","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neulet.2012.03.094","article-title":"Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer\u2019s disease","volume":"516","author":"Han","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2021.101492_bib51","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","article-title":"CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-beta PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts","volume":"14","author":"Hansson","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib52","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.arr.2021.101492_bib53","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1039\/C6MT00019C","article-title":"Lead and manganese levels in serum and erythrocytes in Alzheimer\u2019s disease and mild cognitive impairment: results from the Australian imaging, biomarkers and lifestyle flagship study of ageing","volume":"8","author":"Hare","year":"2016","journal-title":"Metallomics"},{"key":"10.1016\/j.arr.2021.101492_bib54","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.nutr.22.012502.114457","article-title":"Ceruloplasmin metabolism and function","volume":"22","author":"Hellman","year":"2002","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.arr.2021.101492_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13195-018-0395-6","article-title":"Plasma amyloid-beta levels, cerebral atrophy and risk of dementia: a population-based study","volume":"10","author":"Hilal","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2021.101492_bib56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnmol.2020.00038","article-title":"CNS-derived blood exosomes as a promising source of biomarkers: opportunities and challenges","volume":"13","author":"Hornung","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.arr.2021.101492_bib57","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1038\/s41598-017-05390-1","article-title":"Plasma biomarkers are associated with agitation and regional brain atrophy in Alzheimer\u2019s disease","volume":"7","author":"Hsu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2021.101492_bib58","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.18632\/aging.102220","article-title":"Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults","volume":"11","author":"Hu","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.arr.2021.101492_bib59","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3233\/JAD-130854","article-title":"Increased expression of TREM2 in peripheral blood of Alzheimer\u2019s disease patients","volume":"38","author":"Hu","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib60","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/archneurol.2012.18107","article-title":"beta-amyloid dynamics in human plasma","volume":"69","author":"Huang","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib61","doi-asserted-by":"crossref","unstructured":"Huo, Z., Yu, L., Yang, J., Zhu, Y., Bennett, D.A., Zhao, J., 2020. Corrigendum to brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis [Neurobiology of Aging Volume 86, February 2020, Pages 123\u2013133]. Neurobiol Aging 91, 169.","DOI":"10.1016\/j.neurobiolaging.2020.04.004"},{"key":"10.1016\/j.arr.2021.101492_bib62","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cca.2015.07.017","article-title":"Evaluation of dementia by acrolein, amyloid-beta and creatinine","volume":"450","author":"Igarashi","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.arr.2021.101492_bib63","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12974-018-1376-1","article-title":"Circulating levels of IL-1 family cytokines and receptors in Alzheimer\u2019s disease: new markers of disease progression?","volume":"15","author":"Italiani","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2021.101492_bib64","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2021.101492_bib65","doi-asserted-by":"crossref","first-page":"26801","DOI":"10.1038\/srep26801","article-title":"Plasma beta-amyloid in Alzheimer\u2019s disease and vascular disease","volume":"6","author":"Janelidze","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.arr.2021.101492_bib66","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2021.101492_bib67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jamaneurol.2020.4201","article-title":"Associations of plasma phospho-Tau217 levels with tau positron emission tomography in early Alzheimer disease","volume":"78","author":"Janelidze","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib68","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jalz.2019.05.002","article-title":"Concordance between the assessment of Abeta42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid","volume":"15","author":"Jia","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib69","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/alz.12166","article-title":"Blood neuro-exosomal synaptic proteins predict Alzheimer\u2019s disease at the asymptomatic stage","volume":"17","author":"Jia","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib70","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1750-1326-6-69","article-title":"Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer\u2019s disease","volume":"6","author":"Jiang","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.arr.2021.101492_bib71","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.12659\/MSM.914027","article-title":"Exosomes in pathogenesis, diagnosis, and treatment of Alzheimer\u2019s disease","volume":"25","author":"Jiang","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.arr.2021.101492_bib72","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fnagi.2020.00212","article-title":"The validation of multifactor model of plasma abeta 42 and total-tau in combination with MoCA for diagnosing probable Alzheimer disease","volume":"12","author":"Jiao","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2021.101492_bib73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/bpa.12333","article-title":"Understanding aspects of aluminum exposure in Alzheimer\u2019s disease development","volume":"26","author":"Kandimalla","year":"2016","journal-title":"Brain Pathol."},{"key":"10.1016\/j.arr.2021.101492_bib74","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2183\/pjab.90.353","article-title":"Novel plasma biomarker surrogating cerebral amyloid deposition","volume":"90","author":"Kaneko","year":"2014","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.arr.2021.101492_bib75","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/alz.12000","article-title":"Concordance of Lumipulse cerebrospinal fluid t-tau\/Abeta42 ratio with amyloid PET status","volume":"16","author":"Kaplow","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib76","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1096\/fj.14-262048","article-title":"Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer\u2019s disease","volume":"29","author":"Kapogiannis","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2021.101492_bib77","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib78","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41380-020-00923-z","article-title":"Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer\u2019s Disease Neuroimaging Initiative","author":"Karikari","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2021.101492_bib79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/GME.0000000000001160","article-title":"Apolipoprotein E4 genotype in combination with poor metabolic profile is associated with reduced cognitive performance in healthy postmenopausal women: implications for late onset Alzheimer's disease","volume":"26","author":"Karim","year":"2019","journal-title":"Menopause"},{"key":"10.1016\/j.arr.2021.101492_bib80","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/13547500902777608","article-title":"Biochemical markers and the FDA critical path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development","volume":"14","author":"Karsdal","year":"2009","journal-title":"Biomarkers"},{"key":"10.1016\/j.arr.2021.101492_bib81","article-title":"Link between aluminum and the pathogenesis of Alzheimer\u2019s disease: the integration of the aluminum and amyloid cascade hypotheses","volume":"2011","author":"Kawahara","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib82","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1474-4422(20)30231-3","article-title":"Brain insulin resistance in Alzheimer\u2019s disease and related disorders: mechanisms and therapeutic approaches","volume":"19","author":"Kellar","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib83","first-page":"61","article-title":"Decreased mRNA expression of CCL5 [RANTES] in Alzheimer\u2019s disease blood samples","volume":"50","author":"Kester","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.arr.2021.101492_bib84","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00005072-196504000-00002","article-title":"Experimental production of neurofibrillary degeneration. I. Light microscopic observations","volume":"24","author":"Klatzo","year":"1965","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib85","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-200900","article-title":"Blood-based ATN biomarkers of Alzheimer\u2019s disease: a meta-analysis","volume":"79","author":"Koychev","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2019.101898","article-title":"Higher levels of lysosomal associated membrane protein-2 (LAMP-2) in plasma exosomes from Alzheimer\u2019s disease: an exploratory study from South India","volume":"48","author":"Krishna","year":"2020","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.arr.2021.101492_bib87","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2174\/1567205017666201109095657","article-title":"Cerebrospinal fluid and blood CX3CL1 as a potential biomarker in early diagnosis and prognosis of dementia","volume":"17","author":"Kulczynska-Przybik","year":"2020","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2021.101492_bib88","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","article-title":"Are circulating microRNAs peripheral biomarkers for Alzheimer\u2019s disease?","volume":"1862","author":"Kumar","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.arr.2021.101492_bib89","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3233\/JAD-2011-110296","article-title":"Validation of ELISA methods for quantification of total tau and phosporylated-tau181 in human cerebrospinal fluid with measurement in specimens from two Alzheimer\u2019s disease studies","volume":"26","author":"Lachno","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib90","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3233\/JAD-2012-121075","article-title":"Validation of a multiplex assay for simultaneous quantification of amyloid-beta peptide species in human plasma with utility for measurements in studies of Alzheimer\u2019s disease therapeutics","volume":"32","author":"Lachno","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib91","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3233\/JAD-141686","article-title":"Validation and clinical utility of ELISA methods for quantification of amyloid-beta of peptides in cerebrospinal fluid specimens from Alzheimer\u2019s disease studies","volume":"45","author":"Lachno","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib92","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13195-019-0550-8","article-title":"Clinical validation of the Lumipulse G cerebrospinal fluid assays for routine diagnosis of Alzheimer\u2019s disease","volume":"11","author":"Leitao","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2021.101492_bib93","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies-still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.arr.2021.101492_bib94","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fnagi.2017.00300","article-title":"Serum copper, zinc, and iron levels in patients with Alzheimer\u2019s disease: a meta-analysis of case-control studies","volume":"9","author":"Li","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2021.101492_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2019.111175","article-title":"Extracellular vesicles as an emerging tool for the early detection of Alzheimer\u2019s disease","volume":"184","author":"Li","year":"2019","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.arr.2021.101492_bib96","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/JOM.0000000000000063","article-title":"Is the Aluminum Hypothesis dead?","volume":"56","author":"Lidsky","year":"2014","journal-title":"J Occup Environ Med"},{"key":"10.1016\/j.arr.2021.101492_bib97","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clinbiochem.2019.05.005","article-title":"Elecsys((R)) Total-Tau and Phospho-Tau (181P) CSF assays: analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid","volume":"72","author":"Lifke","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.arr.2021.101492_bib98","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jamaneurol.2017.4325","article-title":"Association of beta-amyloid and apolipoprotein E epsilon4 with memory decline in preclinical Alzheimer disease","volume":"75","author":"Lim","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib99","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jalz.2019.04.008","article-title":"Blood amyloid levels and risk of dementia in the ginkgo evaluation of memory study (GEMS): a longitudinal analysis","volume":"15","author":"Lopez","year":"2019","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139233","article-title":"Plasma exosomal miRNAs in persons with and without alzheimer disease: altered expression and prospects for biomarkers","volume":"10","author":"Lugli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2021.101492_bib101","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jalz.2013.01.010","article-title":"CSF biomarker variability in the Alzheimer\u2019s association quality control program","author":"Mattsson","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib102","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","article-title":"Plasma tau in Alzheimer disease","author":"Mattsson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2021.101492_bib103","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib104","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/jamaneurol.2019.0765","article-title":"Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib106","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/archneur.57.1.100","article-title":"Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease","volume":"57","author":"Mehta","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib107","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13195-019-0535-7","article-title":"Association between increased levels of amyloid-beta oligomers in plasma and episodic memory loss in Alzheimer\u2019s disease","volume":"11","author":"Meng","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2021.101492_bib108","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4626540","article-title":"T lymphocytes and inflammatory mediators in the interplay between brain and blood in Alzheimer\u2019s disease: potential pools of new biomarkers","volume":"2017","author":"Mietelska-Porowska","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.arr.2021.101492_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105130","article-title":"TDP-43 and tau oligomers in Alzheimer\u2019s disease, amyotrophic lateral sclerosis, and frontotemporal dementia","volume":"146","author":"Montalbano","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2021.101492_bib110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/jamaneurol.2020.4986","article-title":"Longitudinal associations of blood phosphorylated Tau181 and neurofilament light chain with neurodegeneration in Alzheimer disease","volume":"78","author":"Moscoso","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib111","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/brain\/awaa399","article-title":"Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum","volume":"144","author":"Moscoso","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.arr.2021.101492_bib112","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fnagi.2017.00118","article-title":"Insulin resistance as a link between amyloid-beta and tau pathologies in Alzheimer\u2019s disease","volume":"9","author":"Mullins","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2021.101492_bib113","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/hbm.23494","article-title":"Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer\u2019s disease","volume":"38","author":"Mullins","year":"2017","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.arr.2021.101492_bib114","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-beta biomarkers for Alzheimer's disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.arr.2021.101492_bib115","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1096\/fj.201700359","article-title":"Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer\u2019s disease: inseparable partners in a multifactorial disease","volume":"31","author":"Nixon","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2021.101492_bib116","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jalz.2014.08.099","article-title":"Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer\u2019s disease research","volume":"11","author":"O\u2019Bryant","year":"2015","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib117","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamaneurol.2019.1632","article-title":"Performance of fully automated plasma assays as screening tests for Alzheimer disease-related \u03b2-amyloid status","volume":"76","author":"Palmqvist","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib118","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2021.101492_bib119","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13195-017-0248-8","article-title":"Chemically treated plasma Abeta is a potential blood-based biomarker for screening cerebral amyloid deposition","volume":"9","author":"Park","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2021.101492_bib120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/appy.12077","article-title":"Elevated serum copper and ceruloplasmin levels in Alzheimer\u2019s disease","volume":"6","author":"Park","year":"2014","journal-title":"Asia Pac. Psychiatry"},{"key":"10.1016\/j.arr.2021.101492_bib121","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jamaneurol.2018.4666","article-title":"Assessment of plasma total tau level as a predictive biomarker for dementia and related endophenotypes","volume":"76","author":"Pase","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib122","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13195-019-0549-1","article-title":"Plasma Abeta42\/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study","volume":"11","author":"Perez-Grijalba","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2021.101492_bib123","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrneurol.2017.162","article-title":"Amyloid-beta and tau complexity - towards improved biomarkers and targeted therapies","volume":"14","author":"Polanco","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib124","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2019.2000","article-title":"Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia","volume":"321","author":"Rabinovici","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2021.101492_bib125","article-title":"Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer\u2019s disease","volume":"12","author":"Raket","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib126","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/alz.047539","article-title":"Plasma p\u2010tau181 accurately predicts Alzheimer\u2019s disease pathology at least 8 years prior to post\u2010mortem and improves the clinical characterisation of cognitive decline","volume":"16","author":"Rodriguez","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib127","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00401-018-1868-1","article-title":"Alzheimer\u2019s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers","volume":"136","author":"Sardar Sinha","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.arr.2021.101492_bib128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","article-title":"Contribution of inflammatory processes to Alzheimer\u2019s disease: molecular mechanisms","volume":"24","author":"Sastre","year":"2006","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.arr.2021.101492_bib129","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-140-8-200404200-00047","article-title":"Alzheimer disease: mechanistic understanding predicts novel therapies","volume":"140","author":"Selkoe","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.arr.2021.101492_bib130","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.tips.2018.10.001","article-title":"Copper and zinc dysregulation in Alzheimer\u2019s disease","volume":"39","author":"Sensi","year":"2018","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.arr.2021.101492_bib131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13195-018-0448-x","article-title":"A two-step immunoassay for the simultaneous assessment of Abeta38, Abeta40 and Abeta42 in human blood plasma supports the Abeta42\/Abeta40 ratio as a promising biomarker candidate of Alzheimer\u2019s disease","volume":"10","author":"Shahpasand-Kroner","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2021.101492_bib132","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1038\/s41467-020-19786-7","article-title":"TDP-43 interacts with amyloid-beta, inhibits fibrillization, and worsens pathology in a model of Alzheimer\u2019s disease","volume":"11","author":"Shih","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2021.101492_bib133","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3233\/JAD-150611","article-title":"Association between serum ceruloplasmin specific activity and risk of Alzheimer\u2019s disease","volume":"50","author":"Siotto","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib134","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/B978-0-12-804766-8.00013-3","article-title":"Alzheimer\u2019s disease","volume":"167","author":"Soria Lopez","year":"2019","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0891988719841728","article-title":"Analysis of surface levels of IL-1 receptors and macrophage scavenger receptor I in peripheral immune cells of patients with Alzheimer disease","volume":"32","author":"Spitzer","year":"2019","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib136","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1212\/01.wnl.0000338568.28960.3f","article-title":"Longitudinal prognostic value of serum \"free\" copper in patients with Alzheimer disease","volume":"72","author":"Squitti","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2021.101492_bib137","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.24136","article-title":"Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease","volume":"75","author":"Squitti","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib138","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1515\/cclm-2016-0843","article-title":"Measurements of serum non-ceruloplasmin copper by a direct fluorescent method specific to Cu(II)","volume":"55","author":"Squitti","year":"2017","journal-title":"Clin. Chem. Lab. Med"},{"key":"10.1016\/j.arr.2021.101492_bib139","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-201556","article-title":"Copper Imbalance in Alzheimer\u2019s Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology","author":"Squitti","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib140","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/biom11070960","article-title":"Copper imbalance in Alzheimer\u2019s disease: meta-analysis of serum, plasma, and brain specimens, and replication study evaluating ATP7B gene variants","volume":"11","author":"Squitti","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2021.101492_bib141","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jalz.2019.08.189","article-title":"Prediction of Alzheimer\u2019s disease diagnosis within 14 years through Abeta misfolding in blood plasma compared to APOE4 status, and other risk factors","volume":"16","author":"Stocker","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2021.101492_bib142","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-1-14","article-title":"Microglia and neuroinflammation: a pathological perspective","volume":"1","author":"Streit","year":"2004","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2021.101492_bib143","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00702-015-1369-5","article-title":"Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer\u2019s disease progression: CX3CL1, TREM2, and PPARgamma","volume":"122","author":"Strobel","year":"2015","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.arr.2021.101492_bib144","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neurobiolaging.2020.05.011","article-title":"A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer\u2019s disease","volume":"94","author":"Sugarman","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2021.101492_bib145","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3233\/JAD-140177","article-title":"Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer\u2019s disease","volume":"41","author":"Sun","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib146","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3233\/JAD-200022","article-title":"Plasma neurofilament light and longitudinal progression of white matter hyperintensity in elderly persons without dementia","volume":"75","author":"Sun","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib147","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jalz.2013.12.007","article-title":"The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease","volume":"10","author":"Talbot","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2021.101492_bib148","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3233\/JAD-132144","article-title":"Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer\u2019s disease","volume":"40","author":"Tan","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib149","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3233\/JAD-161277","article-title":"Higher peripheral TREM2 mRNA levels relate to cognitive deficits and hippocampal atrophy in Alzheimer\u2019s disease and amnestic mild cognitive impairment","volume":"58","author":"Tan","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Diagnostic value of plasma phosphorylated tau181 in Alzheimer\u2019s disease and frontotemporal lobar degeneration","volume":"26","author":"Thijssen","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2021.101492_bib151","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease","volume":"57","author":"Tonnies","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib152","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fncel.2020.00019","article-title":"GSK3beta and tau protein in Alzheimer\u2019s disease and epilepsy","volume":"14","author":"Toral-Rios","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.arr.2021.101492_bib153","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","article-title":"Plasma A\u03b21\u201340 and A\u03b21\u201342 and the risk of dementia: a prospective case-cohort study","volume":"5","author":"van Oijen","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.arr.2021.101492_bib154","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.arr.2021.101492_bib155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/JAD-141296","article-title":"Zinc in Alzheimer\u2019s disease: a meta-analysis of serum, plasma, and cerebrospinal fluid studies","volume":"46","author":"Ventriglia","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib156","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","article-title":"Combination of plasma amyloid beta(1-42\/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology","volume":"12","author":"Verberk","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2021.101492_bib157","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12974-018-1220-7","article-title":"Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice","volume":"15","author":"Verite","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.arr.2021.101492_bib158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201232","article-title":"Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer's patients in a human blood brain barrier model","volume":"13","author":"V\u00e9rit\u00e9 J","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2021.101492_bib159","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3233\/JAD-150193","article-title":"Aluminum levels in brain, serum, and cerebrospinal fluid are higher in Alzheimer\u2019s disease cases than in controls: a series of meta-analyses","volume":"47","author":"Virk","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib160","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1258\/jmb.2010.010037","article-title":"Alois Alzheimer (1864-1915) and the Alzheimer syndrome","volume":"19","author":"Vishal","year":"2011","journal-title":"J. Med. Biogr."},{"key":"10.1016\/j.arr.2021.101492_bib161","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3892\/mmr.2020.11118","article-title":"Elevated plasma levels of exosomal BACE1AS combined with the volume and thickness of the right entorhinal cortex may serve as a biomarker for the detection of Alzheimer\u2019s disease","volume":"22","author":"Wang","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.arr.2021.101492_bib162","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-2012-120082","article-title":"Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer\u2019s disease","volume":"31","author":"Wang","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib163","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007947","article-title":"TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response","volume":"15","author":"Wang","year":"2019","journal-title":"PLoS Genet."},{"key":"10.1016\/j.arr.2021.101492_bib164","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1007\/s12035-016-9826-1","article-title":"Associations between hepatic functions and plasma amyloid-beta levels-implications for the capacity of liver in peripheral amyloid-beta clearance","volume":"54","author":"Wang","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.arr.2021.101492_bib165","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-143108","article-title":"Serum iron, zinc, and copper levels in patients with alzheimer\u2019s disease: a replication study and meta-analyses","volume":"47","author":"Wang","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib166","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/0024-3205(92)90112-3","article-title":"Increase of plasma IL-6 concentration with age in healthy subjects","volume":"51","author":"Wei","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.arr.2021.101492_bib167","first-page":"9","article-title":"Diagnostic utility of selected serum dementia biomarkers: amyloid beta-40, amyloid beta-42, tau protein, and YKL-40: a review","author":"Wilczynska","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.arr.2021.101492_bib168","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/brain\/awaa054","article-title":"Plasma tau, neurofilament light chain and amyloid-beta levels and risk of dementia; a population-based cohort study","volume":"143","author":"de Wolf","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.arr.2021.101492_bib169","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s13311-012-0170-5","article-title":"Challenges of bringing next generation sequencing technologies to clinical molecular diagnostic laboratories","volume":"10","author":"Wong","year":"2013","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.arr.2021.101492_bib170","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3233\/JAD-150619","article-title":"Circulating microRNAs as biomarkers of Alzheimer\u2019s disease: a systematic review","volume":"49","author":"Wu","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib171","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1159\/000439214","article-title":"Alterations of the neuroinflammatory markers IL-6 and TRAIL in Alzheimer\u2019s disease","volume":"5","author":"Wu","year":"2015","journal-title":"Dement Geriatr. Cogn. Dis. Extra"},{"key":"10.1016\/j.arr.2021.101492_bib172","first-page":"87","article-title":"The serum exosome derived microRNA-135a, -193b, and -384 were potential Alzheimer\u2019s disease biomarkers","volume":"31","author":"Yang","year":"2018","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.arr.2021.101492_bib173","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13195-019-0499-7","article-title":"Blood amyloid-beta oligomerization associated with neurodegeneration of Alzheimer\u2019s disease","volume":"11","author":"Youn","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2021.101492_bib174","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JAD-200061","article-title":"Blood Amyloid-beta oligomerization as a biomarker of Alzheimer\u2019s disease: a blinded validation study","volume":"75","author":"Youn","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2021.101492_bib175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-018-0407-6","article-title":"Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer\u2019s disease","volume":"10","author":"Zhang","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2021.101492_bib176","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neulet.2013.03.007","article-title":"Combination of plasma tumor necrosis factor receptors signaling proteins, beta-amyloid and apolipoprotein E for the detection of Alzheimer\u2019s disease","volume":"541","author":"Zhang","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2021.101492_bib177","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2174\/1567205011666140317103222","article-title":"Plasma amyloid-beta oligomers and soluble tumor necrosis factor receptors as potential biomarkers of AD","volume":"11","author":"Zhang","year":"2014","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.arr.2021.101492_bib178","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fnagi.2020.00166","article-title":"TDP-43 is elevated in plasma neuronal-derived exosomes of patients with Alzheimer\u2019s disease","volume":"12","author":"Zhang","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.arr.2021.101492_bib179","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-020-2043-0","article-title":"Novel tau filament fold in corticobasal degeneration","volume":"580","author":"Zhang","year":"2020","journal-title":"Nature"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163721002397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163721002397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:56:21Z","timestamp":1761591381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163721002397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":179,"alternative-id":["S1568163721002397"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2021.101492","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current research status of blood biomarkers in Alzheimer\u2019s disease: Diagnosis and prognosis","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2021.101492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101492"}}